Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
MENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124 · cited 4×
“Because GIP and GLP-1 rapidly undergo proteolytic degradation catalyzed by a serine protease DPP-4 (Kieffer et al., 1995; Mentlein et al., 1993), not only intact but also total (i.”
BackgroundInfluentialInhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963 · cited 1×
“Genetic ablation of GIPR and GLP-1R separately or simultaneously in mice revealed their critical roles in the entero-insular axis and confirmed that both GIP and GLP-1 act as incretins (Hansotia et al., 2004; Miyawaki et al., 2002; Preitner et al., 2004; Scrocchi et al., 1996).”
BackgroundSelf-citationThorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903 · cited 1×
“Incretinbound receptors increase intracellular cAMP levels (Drucker et al., 1987; Szecowka et al., 1982), thereby activating protein kinase A (PKA) (Fehmann et al., 1995) and Epac2/cAMP-GEFII (Holz, 2004).”
BackgroundSTIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN. 1
Dupre, J., Ross, S. A., Watson, D., & Brown, J. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-5-826 · Cited by 860
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793 · cited 1×
“Genetic ablation of GIPR and GLP-1R separately or simultaneously in mice revealed their critical roles in the entero-insular axis and confirmed that both GIP and GLP-1 act as incretins (Hansotia et al., 2004; Miyawaki et al., 2002; Preitner et al., 2004; Scrocchi et al., 1996).”
BackgroundDeacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738
Hamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649 · cited 1×
“…on enteroglucagons revealed that GLP-1, a 31-amino-acid hormone produced from proglucagon and secreted from L cells of the lower intestine and colon (Bell et al., 1983), stimulates insulin secretion in isolated islets (Schmidt et al., 1985) as well as in healthy volunteers (Kreymann et al., 1987).”
BackgroundT., V., T., K., S., M., & J., H. (2002) · Diabetologia · doi:10.1007/s00125-002-0878-6 · Cited by 518
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502 · cited 1×
“The anti-apoptotic function of GLP-1 on pancreatic b cells was suggested by studies of pancreas of exendin-4-treated db/db mice or GLP-1-infused VDF rats, which showed an increase in b cell mass and a decrease in apoptotic b cells (Farilla et al., 2002; Wang and Brubaker, 2002).”
BackgroundSecretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
Nauck, M. A., Vardarli, I., Deacon, C. F., Holst, J. J., & Meier, J. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1896-4 · Cited by 465
Vilsbøll, T., Krarup, T., Madsbad, S., & Holst, J. J. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00111-3 · Cited by 430
Højberg, P. V., Vilsbøll, T., Rabøl, R., Knop, F. K., Bache, M., Krarup, T., Holst, J. J., & Madsbad, S. (2009) · Diabetologia · doi:10.1007/s00125-008-1195-5 · Cited by 414
Meier, J. J., Nauck, M. A., Kranz, D., Holst, J. J., Deacon, C. F., Gaeckler, D., Schmidt, W. E., & Gallwitz, B. (2004) · Diabetes · doi:10.2337/diabetes.53.3.654 · Cited by 334 · cited 1×
“The apparent half-lives for intact GIP and GLP-1 have been determined as approximately 5 and 2 min, respectively (Deacon et al., 1995; Meier et al., 2004; Vilsboll et al., 2006).”
Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice
Tschen, S.-I., Dhawan, S., Gurlo, T., & Bhushan, A. (2009) · Diabetes · doi:10.2337/db08-1651 · Cited by 331 · cited 1×
“The lack of b cell proliferation in patients with T2DM could be explained by the finding that effects of incretins on b cell proliferation are age-dependent (Tschen et al., 2009).”
BackgroundParker, H. E., Habib, A. M., Rogers, G. J., Gribble, F. M., & Reimann, F. (2009) · Diabetologia · doi:10.1007/s00125-008-1202-x · Cited by 324 · cited 1×
“Although it is not discussed in this review, recent advances in understanding the molecular mechanisms underlying GIP and GLP-1 secretion from K and L cells (Parker et al., 2009) should clarify the differing results in the various studies.”
ResultHansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309 · cited 8×
“Future investigation on signaling cascades in the downstream of GIPR and GLP-1R of pancreatic b cells should not only shed light on selective preservation of insulinotropic actions to pharmacological GLP-1 levels, and but also it provides further therapeutic targets to treat diabetes.”
BackgroundInfluentialSelf-citationRenström, E., Eliasson, L., & Rorsman, P. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.105bl.x · Cited by 299 · cited 2×
“Depolarization opens the voltage-gated Ca2þ channels (VDCC), allowing increase of intracellular Ca2þ concentrations, which then mobilizes Ca2þ from intracellular stores through PKA- and Epac2dependent mechanisms (Ding and Gromada, 1997; Kang et al., 2001; Kang et al., 2003; Renstrom et al., 1997; Yaekura et al., 1996).”
BackgroundKang, G., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. L., Schwede, F., Genieser, H.-G., & Holz, G. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211682200 · Cited by 298 · cited 2×
“Depolarization opens the voltage-gated Ca2þ channels (VDCC), allowing increase of intracellular Ca2þ concentrations, which then mobilizes Ca2þ from intracellular stores through PKA- and Epac2dependent mechanisms (Ding and Gromada, 1997; Kang et al., 2001; Kang et al., 2003; Renstrom et al., 1997; Yaekura et al., 1996).”
BackgroundOn the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane
Moore, B., Edie, E. S., & Abram, J. H. (1906) · Biochemical Journal · doi:10.1042/bj0010028 · Cited by 279 · cited 2×
“that administration of gut extracts reduces the amount of urine sugars in patients with diabetes, presumably through stimulation of endocrine pancreas (Moore, 1906).”
BackgroundMeier, J. J., & Nauck, M. A. (2010) · Diabetes · doi:10.2337/db09-1899 · Cited by 215
Lynn, F. C., Pamir, N., Ng, E. H. C., McIntosh, C. H. S., Kieffer, T. J., & Pederson, R. A. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1004 · Cited by 208
Mentis, N., Vardarli, I., Köthe, L. D., Holst, J. J., Deacon, C. F., Theodorakis, M., Meier, J. J., & Nauck, M. A. (2011) · Diabetes · doi:10.2337/db10-1332 · Cited by 197
Piteau, S., Olver, A., Kim, S.-J., Winter, K., Pospisilik, J. A., Lynn, F., Manhart, S., Demuth, H.-U., Speck, M., Pederson, R. A., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.115 · Cited by 130 · cited 2×
“Various studies in model animals suggest down-regulation of GIPR mRNA (Lynn et al., 2001; Lynn et al., 2003; Piteau et al., 2007; Younan and Rashed, 2007), accelerated degradation of GIPR (Zhou et al., 2007), and alternative splicing of GIPR mRNA (Harada et al., 2008), all of which might contribute…”
BackgroundEbert, R., Unger, H., & Creutzfeldt, W. (1983) · Diabetologia · doi:10.1007/bf00257346 · Cited by 120
Volz, A., Göke, R., Lankat-Buttgereit, B., Fehmann, H.-C., Bode, H. P., & Göke, B. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01006-z · Cited by 96 · cited 1×
“Both GIP and GLP-1 exert their effects by binding to their specific receptors, the GIP receptor (GIPR) (Gremlich et al., 1995; Volz et al., 1995; Wheeler et al., 1995; Yamada et al., 1995; Yasuda et al., 1994) and the GLP-1 receptor (GLP-1R) (Dillon et al., 1993; Stoffel et al., 1993; Thorens,…”
BackgroundLynn, F. C., Thompson, S. A., Pospisilik, J. A., Ehses, J. A., Hinke, S. A., Pamir, N., McIntosh, C. H. S., & Pederson, R. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0243fje · Cited by 91
Fujimoto, W., Miki, T., Ogura, T., Zhang, M., Seino, Y., Satin, L. S., Nakaya, H., & Seino, S. (2009) · Diabetologia · doi:10.1007/s00125-009-1306-y · Cited by 32 · cited 2×
“Although the involvement of niflumic acid-sensitive ion channels has been shown in this process (Fujimoto et al., 2009), further investigation is required to understand the potential diversity in the downstream mechanisms of GIPR and GLP-1R.”
BackgroundSelf-citation
Cited by
Natural Products for the Treatment of Type 2 Diabetes Mellitus
Ríos, J., Francini, F., & Schinella, G. (2015) · Planta Medica · doi:10.1055/s-0035-1546131 · Cited by 446
β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
Yabe, D., Seino, Y., Fukushima, M., & Seino, S. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0602-9 · Cited by 328
Self-citationRegulation of Glucose Homeostasis by GLP-1
Nadkarni, P., Chepurny, O. G., & Holz, G. G. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-800101-1.00002-8 · Cited by 287
Liraglutide Improves Pancreatic Beta Cell Mass and Function in Alloxan-Induced Diabetic Mice
Tamura, K., Minami, K., Kudo, M., Iemoto, K., Takahashi, H., & Seino, S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126003 · Cited by 70
Salles, G. N., Calió, M. L., Hölscher, C., Pacheco-Soares, C., Porcionatto, M., & Lobo, A. O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107813 · Cited by 71
Metadata
- Authors
- Yabe, D., & Seino, Y.
- Venue
- Progress in Biophysics and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 107
- Issue
- 2
- Pages
- 248-256
- ISSN
- 0079-6107 (ISSN-L)
- OpenAlex
- W2051903648
- Cited by
- 188
- References
- 32
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.